v3.26.1

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 179,325	$ 90,634
Short-term investments	390,931	202,032
Accounts receivable, net	140,672	165,491
Inventories	126,400	128,769
Prepaid and other current assets	49,772	31,217
Total current assets	887,100	618,143
Property and equipment, net	83,250	83,580
Operating lease right-of-use assets	95,740	96,172
Equity method investments	56,486	60,351
Other long-term assets	30,818	22,866
Total assets	1,153,394	881,112
Current liabilities:
Accounts payable	59,860	47,067
Accrued expenses	19,238	21,012
Employee-related liabilities	55,695	70,409
Operating lease liabilities	20,109	19,472
Deferred revenue	8,954	9,527
Other current liabilities	84,103	75,237
Total current liabilities	247,959	242,724
Convertible senior notes, net - long-term	601,768	310,036
Operating lease liabilities - long-term	112,858	114,967
Deferred revenue - long-term	7,994	8,474
Other long-term liabilities	50,412	49,741
Total liabilities	1,020,991	725,942
Commitments and contingencies (Note 14)	0	0
Stockholders’ equity:
Common stock, $0.001 par value; 200,000 shares authorized, 68,504 and 68,291 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	69	68
Additional paid-in capital	1,400,218	1,402,044
Accumulated other comprehensive income	5,044	5,593
Accumulated deficit	(1,272,928)	(1,252,535)
Total stockholders’ equity	132,403	155,170
Total liabilities and stockholders’ equity	$ 1,153,394	$ 881,112

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

TANDEM DIABETES CARE INC 10-Q